Evidence map›Paper›PMID 41523487›Full record

ReviewCureus2025

Thyrotoxic Periodic Paralysis (TPP): A Comprehensive Review with Regional Insights from the Middle East.

Fahad S Alrashidi

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Lifestyle and dietary measures in Periodic Paralyses.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Fahad S AlrashidiInternal Medicine/Nephrology, Ad Diriyah Hospital, Riyadh Third Health Cluster, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThyrotoxic periodic paralysis (TPP) is a rare but potentially life-threatening cause of acute flaccid paralysis, characterized by hypokalemia in the setting of thyrotoxicosis and often misdiagnosed in emergency departments.

methodsWe conducted a narrative literature review of TPP in adults using major databases up to 31 October 2025, with a focus on clinical presentation, precipitants, diagnostic pitfalls, and management, and we synthesized Middle Eastern case data alongside global experience.

resultsTPP typically affects younger males and may be the first manifestation of hyperthyroidism. High-carbohydrate meals, strenuous exercise, and β-agonists are common triggers. Misdiagnosis as Guillain-Barré syndrome or other neuromuscular conditions is frequent, particularly when thyrotoxicosis is subtle. Middle Eastern reports suggest similar clinical patterns but highlight delayed recognition and variable access to thyroid testing. Early correction of hypokalemia, non-selective beta (β)-blockade, and definitive control of thyrotoxicosis are essential to prevent recurrences.

conclusionsAn emergency department (ED)-focused approach that routinely considers TPP in acute flaccid paralysis, integrates rapid thyroid function testing, and follows structured potassium replacement and β-blocker protocols can reduce diagnostic delay and improve outcomes. Incorporating regional data may help tailor awareness campaigns and management pathways in Middle Eastern and other underrepresented settings.

Indexed as

arrhythmiaemergency medicinegeneticshyperthyroidismhypokalemiakcnj18/kir2.6managementmiddle eastpotassium reboundthyrotoxic periodic paralysis

Identifiers

PMID41523487
PMCPMC12782297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.